Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Cancer Prevention02:59

Cancer Prevention

8.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.6K
Primary Healthcare Services01:30

Primary Healthcare Services

2.6K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
2.6K
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

15.3K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
15.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diel Activity Patterns of Bobcats and Domestic Cats in the Houston Metropolitan Area.

microPublication biology·2026
Same author

Beyond the Surface: Duodenal-Type Follicular Lymphoma Diagnosed Despite Normal-Appearing Duodenal Mucosa and Absence of Focal Duodenal FDG Uptake.

Case reports in gastrointestinal medicine·2026
Same author

Devices and approaches for leaflet modification.

JTCVS structural and endovascular·2026
Same author

Correction: Heart Disease in Older Women: Unique Challenges in Diagnosis and Management.

Current cardiology reports·2026
Same author

Diagnostic Performance of Two CCTA Derived Noninvasive FFR Techniques: The TripleFFR Study.

Circulation. Cardiovascular imaging·2026
Same author

Heart Disease in Older Women: Unique Challenges in Diagnosis and Management.

Current cardiology reports·2026
Same journal

Immunity gaps for several vaccine preventable diseases in Norway.

Vaccine·2026
Same journal

Australians' attitudes to mRNA vaccination in humans and animals: A cross-sectional survey.

Vaccine·2026
Same journal

Immunoproteomics and reverse vaccinology identify a protective T-cell epitope from Fonsecaea pedrosoi for experimental chromoblastomycosis.

Vaccine·2026
Same journal

Retraction notice to "Effectiveness of prescription-based influenza vaccination services among older adults in Binzhou, China: A cluster-randomized controlled trial" [Vaccine 82 (2026) 128588].

Vaccine·2026
Same journal

Barriers and facilitators to COVID-19 vaccination programme implementation in Ireland: a qualitative study of implementation stakeholders using CFIR.

Vaccine·2026
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
See all related articles

Related Experiment Video

Updated: Mar 7, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K

Increasing HPV vaccine uptake using a "start at 9"strategy: A pilot program.

Sarah Malik1, Sarah Gu1, Jaclyn Sisskind1

  • 1Department of Pediatrics, SUNY Upstate Medical University, Syracuse, NY, United States of America.

Vaccine
|March 5, 2026
PubMed
Summary
This summary is machine-generated.

Recommending the human papillomavirus (HPV) vaccine at 9 years old significantly boosts timely vaccination completion rates by age 13. This multi-level program proved feasible and effective in pediatric practices.

Keywords:
Adolescent vaccinesHPVVaccination rates

More Related Videos

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.4K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K

Related Experiment Videos

Last Updated: Mar 7, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.4K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K

Area of Science:

  • Pediatric infectious disease prevention
  • Vaccination and immunization strategies
  • Public health interventions

Background:

  • Human papillomavirus (HPV) vaccine completion rates by age 13 remain suboptimal.
  • Earlier initiation of HPV vaccination may improve timely completion.
  • Current strategies need enhancement to meet public health goals.

Purpose of the Study:

  • To evaluate the impact of recommending the HPV vaccine at 9 years of age on vaccine completion rates.
  • To assess the feasibility of implementing a multi-level intervention program for early HPV vaccination.
  • To analyze factors influencing HPV vaccine uptake in pediatric settings.

Main Methods:

  • Implementation of a multi-level program including policy changes, provider education, and EHR modifications in two pediatric practices.
  • Monthly chart reviews and quarterly data collection on HPV vaccination status and demographics for 9-12-year-olds.
  • Analysis of HPV vaccine uptake and documentation rates before and after program implementation.

Main Results:

  • Median HPV vaccine uptake in 9-10-year-olds increased from 8% to 41% (urban) and 3% to 23% (suburban).
  • HPV vaccine completion rates for 9-12-year-olds significantly increased (p < 0.001) in both practices.
  • Strong correlation observed between provider recommendation documentation and HPV vaccination.

Conclusions:

  • A multi-level program recommending the HPV vaccine at 9 years is feasible and effective.
  • Early HPV vaccine recommendation improves completion rates by age 13.
  • This intervention demonstrates a successful strategy for enhancing pediatric immunization coverage.